A detailed history of Lavaca Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lavaca Capital LLC holds 10,834 shares of MRK stock, worth $1.08 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
10,834
Previous 10,734 0.93%
Holding current value
$1.08 Million
Previous $1.33 Million 7.38%
% of portfolio
0.53%
Previous 0.68%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $11,115 - $12,897
100 Added 0.93%
10,834 $1.23 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $207,682 - $241,996
1,834 Added 20.61%
10,734 $1.42 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $242,635 - $264,046
-2,422 Reduced 21.39%
8,900 $970,000
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $1.09 Million - $1.21 Million
-10,592 Reduced 48.33%
11,322 $1.17 Million
Q2 2023

Aug 25, 2023

BUY
$108.61 - $118.38 $2.38 Million - $2.59 Million
21,914 New
21,914 $2.53 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $74,837 - $83,503
727 Added 1.14%
64,746 $6.89 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $171,032 - $219,287
1,956 Added 3.15%
64,019 $7.1 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $86,981 - $97,713
-1,029 Reduced 1.63%
62,063 $5.52 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $559,883 - $634,655
6,706 Added 11.89%
63,092 $5.62 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $3.58 Million - $4.01 Million
-48,696 Reduced 46.34%
56,386 $4.63 Million
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $433 - $543
6 Added 0.01%
105,082 $8.05 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $122,572 - $134,799
1,710 Added 1.65%
105,076 $7.89 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $1.16 Million - $1.28 Million
-16,467 Reduced 13.74%
103,366 $8.04 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $569,403 - $670,698
8,269 Added 7.41%
119,833 $9.24 Million
Q4 2020

Jan 13, 2021

BUY
$71.77 - $79.65 $1.59 Million - $1.76 Million
22,112 Added 24.72%
111,564 $9.13 Million
Q3 2020

Nov 10, 2020

SELL
$73.18 - $82.95 $174,900 - $198,250
-2,390 Reduced 2.6%
89,452 $7.42 Million
Q2 2020

Aug 11, 2020

SELL
$70.42 - $80.13 $56,124 - $63,863
-797 Reduced 0.86%
91,842 $7.1 Million
Q1 2020

May 12, 2020

SELL
$63.36 - $87.82 $297,285 - $412,051
-4,692 Reduced 4.82%
92,639 $7.13 Million
Q4 2019

Feb 05, 2020

BUY
$77.58 - $87.54 $1,318 - $1,488
17 Added 0.02%
97,331 $8.85 Million
Q3 2019

Nov 04, 2019

SELL
$76.08 - $82.93 $29,899 - $32,591
-393 Reduced 0.4%
97,314 $8.19 Million
Q2 2019

Jul 29, 2019

BUY
$69.84 - $81.59 $151,482 - $176,968
2,169 Added 2.27%
97,707 $8.19 Million
Q1 2019

Apr 11, 2019

BUY
$69.58 - $79.36 $347,900 - $396,800
5,000 Added 5.52%
95,538 $7.95 Million
Q4 2018

Jan 22, 2019

BUY
$65.24 - $75.71 $5.91 Million - $6.85 Million
90,538 New
90,538 $6.92 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Lavaca Capital LLC Portfolio

Follow Lavaca Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lavaca Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lavaca Capital LLC with notifications on news.